Interestingly, the druggability of NLRP3 has been recently demonstrated in (neuro) inflammatory disorders such as Parkinson’s disease, amyotrophic lateral sclerosis (ALS) or cardiovascular disease [13]. The gene discussed is NLRP3; the disease is amyotrophic lateral sclerosis.